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DESIGNING A MULTI-CENTER DOSE-PAINTING TRIAL: METHOD-
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Purpose: Intensity modulated radiotherapy has reached a status that is suf-
ﬁcient to test dose-painting (DP) in clinical trials, such as for head-and-neck
and lung cancer. Both dose-painting by numbers (DPBN) or by dose painting
by contours/volumes (DPBC) are hypothesized to individualize the treatment
of cancer patients to provide the most optimal treatment. We will discuss the
methodology and possible pitfalls for designing DP trials and use our currently
ongoing multi-center randomised phase II PET-boost trial as an example.
Materials: Our multi-center DPBC trial for stage II-III non-small cell lung can-
cer patients (PET-boost trial: NCT 01024829) recently started. We hypoth-
esised that DPBC based on pre-radiotherapy PET imaging improves local
control of the primary tumour. The following criteria were taken into account
in the design of this DP trial: 1) Forcing iso-toxicity is mandatory to prove
that DP is superior compared to homogeneous dose delivery without the bias
of more toxicity and/or more integral target dose in the experimental arm; 2)
Standardization of the imaging techniques is of utmost importance as well as
3) standardized delineation of organs-at-risk (OAR) and 4) treatment planning
techniques and delivery should be comparable in all centers.
Results: We designed a randomized phase II trial on dose-escalation of
advanced NSCLC patients to the primary tumour. A two-arm randomized
design was chosen. Arm A: homogeneous boost to the entire primary tu-
mour target volume. Arm B: boost to the high FDG-uptake region (SUV
max>50%) within the primary tumour without decreasing the minimal PTV
dose below our current standard (66 Gy/ 24 fractions). 1) Both arms A
and B are normalized, i.e. forced isotoxic for the mean lung dose (MLD) to
each other by performing dual arm treatment planning for every patient and
forcing a downscaling of the treatment plan with the highest MLD towards
equal MLD of the other arm. 2) The FDG-PET imaging is standardized us-
ing the NEDPAS protocol (Boellaard et al. 2009) for all PET scanners used
in the participating centres. 3) An atlas was created (freely downloadable at
http://www.maastro.nl/web/show/id=62542/langid=432) and is used to stan-
dardize delineations of the OARs. 4) A feasibility treatment planning study
prior to start of the trial was performed to assure that the dose-escalation
levels for identical patients were similar.
Conclusions: Designing a dose-painting trial is not trivial. Unbalanced or
single arm studies will be biased against the fact that the integral dose in
such DP trials is higher, hence leading to improved local control, thus not in-
vestigating dose redistribution in the PTV but also dose-escalation. A control
arm with approximately equal toxicity and preferably also equal integral dose
to the target structures might provide solid evidence that DP has an added
value towards treatment outcome.
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Purpose: For credentialing of an international IMRT head and neck can-
cer trial, three identical anthropomorphic head phantoms were obtained from
an external dosimetry laboratory (EDL). The phantom’s insert contains eight
TLDs marking primary and secondary PTVs and one organ at risk (OAR;
Figure 1). GAFchromic dosimetry ﬁlm is placed through the primary PTV in
the axial and sagittal planes and steel needles act as ﬁducial markers. Our
objective was to investigate the timeliness, reproducibility and accuracy of
reloading the insert independent of the EDL.
2http://www.maastro.nl/web/show/id=62542/langid=43
Materials: Four sequential CT simulation scans were performed; between
each, the insert was completely disassembled, reassembled (TLD, ﬁlm), and
the scans were co-registered. KV-CT doses were separately extracted from
TLD doses based on EDL procedures. Following the ﬁnal scan, the insert
was left intact; volumes were delineated and an IMRT plan created with the
following dosimetric objectives: primary and secondary PTVs should receive
6.6Gy and 5.4Gy respectively, and maximum allowed dose to the OAR is
4.5Gy. The phantom was irradiated with this plan three times, with the insert
reloaded each time. The fourth and ﬁnal irradiation was to enable extraction
of dose contributed by position veriﬁcation (MV-CT).
Results: On average, it took 15-20 minutes to reload the dosimetry insert,
which moved <2mm between CT acqusitions. The degree of exposure of
GAFchromic ﬁlm was not different from background compared to KV-CT. MV-
CT dose based on TLD evaluation was <0.01Gy. For the three irradiations,
the average ratio between the actual dose delivered to the primary PTV (mea-
sured by TLD exposure at the EDL) and dose prospectively planned was 0.96,
0.96 and 0.95 (acceptable range 0.93-1.07). Values for the secondary PTV
were 0.95, 0.96 and 0.95. Film dose maps conﬁrmed concordance (<0.5mm
displacement) of the calculated and observed dose gradient in the region be-
tween the primary PTV and the OAR for each irradiation.
Conclusions: This conﬁrms both the feasibility and equivalent accuracy of
reloading of the dosimetry insert independent of the EDL, permitting parallel
phantom irradiation via site visits for IMRT credentialing. To date, this has
been completed in 14 institutions (seven each via site visits and direct ship-
ment of phantoms from the EDL to participating institutions).
Figure 1. Cross-sectional view of the insert in the axial ﬁlm plane as found in
irradiation instructions of the EDL.
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Purpose: Extensive multifactorial data sharing is widely recognized as cru-
cial for current and future radiotherapy research, clinical research in general,
but the cost, time and effort it takes to share data is often a roadblock. The
purpose of this work is to present a quick, ad-hoc data sharing infrastruc-
ture between two radiotherapy departments based on free or open source
products.
Materials: A collaboration and data transfer agreement was signed which
describes the type of data, the permitted use and the protection of the data.
This agreement was submitted to and approved by the local ethical authority.
On a research workstation (Windows XP 32-bit, Intel Xeon, 2.53GHz, 4GB
RAM) the following software was installed: SQL Server 2008 (free Express
version, Microsoft, Redmond, WA); Clear Canvas Image Server and Worksta-
tion (both free and open source, Clear Canvas, Toronto, Canada); DCMTK
DICOM toolkit (free and open source, Ofﬁs, Oldenburg, Germany); RSNA
Clinical Trial Processor CTP (free and open source, RSNA, Oakbrook, IL) and
Matlab Runtime Component (free, Mathworks, Natick, MA). Nightly text and
DICOM synchronization with the local clinical databases was implemented.
Part of the synchronization mechanism is an extensive de-identiﬁcation and
the translation of local terms to a standardized terminology (SNOMED).
